GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 227.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.50 (1.096%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 227.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Bank of America cuts Melrose, raises Spectris

Wed, 27th Apr 2022 09:42

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

----------

FTSE 100

----------

Deutsche Bank cuts Diageo to 'hold' (buy) - price target 3,900 (4,650) pence

----------

Bank of America cuts Melrose Industries to 'neutral' ('buy') - target 130 (216) pence

----------

Goldman Sachs raises WPP price target to 1,270 (1,235) pence - 'neutral'

----------

JPMorgan raises WPP price target to 1,330 (1,280) pence - 'overweight'

----------

JPMorgan cuts Aveva price target to 3,625 (4,500) pence - 'overweight'

----------

Deutsche Bank cuts Coca-Cola HBC target to 2,585 (2,800) pence - 'buy'

----------

Barclays raises Coca-Cola HBC price target to 1,900 (1,800) pence - 'overweight'

----------

RBC cuts Land Securities price target to 950 (1,000) pence - 'outperform'

----------

RBC cuts British Land price target to 475 (500) pence - 'sector perform'

----------

RBC cuts Segro price target to 1,250 (1,325) pence - 'sector perform'

----------

JPMorgan raises Persimmon price target to 3,110 (2,830) pence - 'overweight'

----------

JPMorgan cuts Taylor Wimpey price target to 180 (190) pence - 'overweight'

----------

Barclays cuts AB Foods price target to 2,300 (2,500) pence - 'overweight'

----------

Goldman Sachs cuts AB Foods price target to 1,775 (2,015) pence - 'sell'

----------

JPMorgan cuts AB Foods price target to 1,940 (2,100) pence - 'overweight'

----------

Credit Suisse cuts HSBC price target to 515 (530) pence - 'neutral'

----------

Bank of America raises Natwest price target to 360 (335) pence - 'buy'

----------

Jefferies raises Intercontinental Hotels target to 6,000 (5,750) pence - 'buy'

----------

DZ Bank raises Anglo American price target to 2,350 (2,250) pence - 'sell'

----------

FTSE 250

----------

Bank of America raises Spectris to 'buy' ('neutral') - target 3400 (2850) pence

----------

UBS raises Beazley to 'buy' (sell) - price target 492 (440) pence

----------

UBS cuts Lancashire Holdings price target to 678 (752) pence - 'buy'

----------

JPMorgan raises Drax price target to 950 (700) pence - 'overweight'

----------

JPMorgan raises WH Smith price target to 1,760 (1,737) pence - 'neutral'

----------

Deutsche Bank cuts Britvic price target to 855 (885) pence - 'hold'

----------

RBC cuts Great Portland price target to 600 (625) pence - 'underperform'

----------

RBC cuts Workspace price target to 1,000 (1,050) pence - 'outperform'

----------

RBC cuts Derwent London price target to 2750 (2850) pence - 'underperform'

----------

RBC cuts Hammerson price target to 32 (33) pence - 'sector perform'

----------

RBC cuts Big Yellow price target to 1,375 (1,450) pence - 'underperform'

----------

RBC cuts Tritax Eurobox price target to 130 (135) pence - 'outperform'

----------

RBC cuts Tritax Big Box price target to 265 (275) pence - 'outperform'

----------

RBC cuts LondonMetric Property price target to 305 (325) pence - 'outperform'

----------

Barclays cuts Jupiter Fund price target to 180 (210) pence - 'underweight'

----------

JPMorgan cuts Jupiter Fund price target to 200 (225) pence - 'neutral'

----------

Barclays cuts IWG price target to 300 (330) pence - 'overweight'

----------

Jefferies cuts Puretech Health price target to 485 (510) pence - 'buy'

----------

Jefferies cuts JD Wetherspoon price target to 1,175 (1,300) pence - 'buy'

----------

RBC raises Hilton Food price target to 1,500 (1,400) pence - 'outperform'

----------

Bank of America cuts Aston Martin price target to 700 (1,250) pence - 'underperform'

----------

SMALL CAP

----------

Bank of America cuts Asos price target to 1,160 (1,450) pence - 'underperform'

----------

Berenberg raises Anglo Pacific price target to 260 (250) pence - 'buy'

----------

Deutsche Bank cuts Fevertree drinks target to 3,060 (3,350) p - 'buy'

----------

Deutsche Bank cuts South32 price target to 300 (320) pence - 'hold'

----------

Jefferies cuts South32 price target to 290 (310) pence - 'hold'

----------

UBS cuts South32 price target to 325 (340) pence - 'buy'

----------

RBC cuts Empiric Student Property target to 105 (110) pence - 'outperform'

----------

RBC cuts Supermarket Income REIT price target to 140 (150) pence - 'outperform'

----------

RBC cuts Warehouse REIT price target to 160 (180) pence - 'sector perform'

----------

RBC raises Impact Healthcare REIT target to 140 (135) pence - 'outperform'

----------

Jefferies cuts Restaurant Group price target to 130 (170) pence - 'buy'

----------

Jefferies raises PPHE Hotels price target to 2,100 (1,750) pence - 'buy'

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
18 May 2020 13:46

UK DIRECTOR DEALINGS SUMMARY: Novacyt Chair And CEO Step In To Buy

UK DIRECTOR DEALINGS SUMMARY: Novacyt Chair And CEO Step In To Buy

Read more
9 Apr 2020 12:54

PureTech Health Swings To Annual Profit On Exceptional Gains

PureTech Health Swings To Annual Profit On Exceptional Gains

Read more
9 Apr 2020 09:09

Puretech Health revenues slide, losses widen

(Sharecast News) - Clinical-stage biotherapeutics company Puretech Health posted weaker full-year revenues and a widened operating loss on Thursday and also noted it was yet to see any impact to ongoing work as a result of the Covid-19 outbreak.

Read more
2 Apr 2020 16:09

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
3 Mar 2020 16:07

PureTech Health Doses First Patient In Phase 1 LYT-100 Study

PureTech Health Doses First Patient In Phase 1 LYT-100 Study

Read more
3 Mar 2020 08:04

PureTech begins next study of lymphoedema drug candidate

(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health announced on Tuesday that the first participant has been dosed in a clinical study of 'LYT-100', its wholly-owned product candidate for the potential treatment of lymphoedema and other fibrotic conditions.

Read more
25 Feb 2020 14:10

PureTech Health Affiliate Akili Posts Encouraging ADHD Study Results

PureTech Health Affiliate Akili Posts Encouraging ADHD Study Results

Read more
24 Jan 2020 12:45

Friday broker round-up

(Sharecast News) - TT Electronics: Jefferies downgrades to hold with a target price of 265p.

Read more
23 Jan 2020 07:44

PureTech sells shares in Karuna affiliate for $200m

(Sharecast News) - Clinical stage biotech company PureTech Health said it had sold 2.1m shares of its affiliate Karuna Therapeutics for $200m.

Read more
15 Jan 2020 13:26

PureTech Health Unit Akili's AKL-T01 Study Achieves Primary Endpoint

PureTech Health Unit Akili's AKL-T01 Study Achieves Primary Endpoint

Read more
19 Dec 2019 17:33

PureTech Health Affiliate Reports Positive Results In Alopecia Study

PureTech Health Affiliate Reports Positive Results In Alopecia Study

Read more
19 Dec 2019 08:25

PureTech affiliate Follica reports 44% improvement in hair-loss study

(Sharecast News) - PureTech Health on Thursday said results from a study into a hair loss treatment developed by its affiliate Follica demonstrated a statistically significant 44% improvement in hair count.

Read more
17 Dec 2019 16:13

PureTech's Gelesis Partners With Telehealth Firm Ro For Plenity In US

PureTech's Gelesis Partners With Telehealth Firm Ro For Plenity In US

Read more
12 Dec 2019 15:52

PureTech Health Investee Akili Delivers Positive AKL-T03 Trial Results

PureTech Health Investee Akili Delivers Positive AKL-T03 Trial Results

Read more
10 Dec 2019 14:47

PureTech Health's Vedanta Launches First-In-Patient Study Of VE800

PureTech Health's Vedanta Launches First-In-Patient Study Of VE800

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.